Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Teen smoking, drinking decline, while mental health, dietary habits worsen
Yozma hints at US$100m funding for Korean biotech ventures
By Korea HeraldPublished : June 30, 2016 - 17:36
[THE INVESTOR] Yozma Group chairman Yigal Erlich on June 30 hinted at new funding worth up to US$100 million in Korea’s biotech venture firms.
The head of the leading venture capitalist based in Israel was visiting Seoul to attend a conference among bioscience experts and industry officials.
Touting Korea’s advanced medical techniques, he showed expectations about the growth potential of the nation’s biotech industry.
During his visit, Yozma Group also signed a memorandum of understanding with the Korea Bio Technology Organization to nurture some 1,000 biotech start-ups.
(theinvestor@heraldcorp.com)
-
Articles by Korea Herald
